Home/ Stocks/ MXCT

MaxCyte, Inc. Common Stock

MXCT XNAS

$0.74 -0.06 (-7.52%) ▼ 15-min delayed

Open

$0.76

High

$0.77

Low

$0.74

Volume

729.8K

Market Cap

$80.74M

About MaxCyte, Inc. Common Stock

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Sector: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH Employees: 114 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$6.83M	$-12,416,000	$-0.12
Q2 2025	$8.51M	$-12,357,000	$-0.12
Q1 2025	$10.39M	$-10,261,000	$-0.10
FY 2024	$38.63M	$-41,055,000	$-0.39

Related Market News

No specific coverage for MXCT yet. Check out our latest market news or earnings calendar.

Get MXCT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on MaxCyte, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.